Single patient reporting melanotan II and sunbed use
How the study was set up
A case report describes a young woman who used Melanotan II and tanning beds before a suspicious skin lesion was removed.
What the researchers measured
Clinical skin examination and tissue histology established a melanoma diagnosis.
How to read this evidence
A report of individual cases can highlight a possible safety signal. It cannot show how often an event occurs or prove that the peptide caused it.
Results in context
The exposures coincided with melanoma, but a single case with tanning-bed exposure cannot establish the peptide's separate causal contribution or calculate risk.
What this does not establish
A case report with concurrent ultraviolet exposure cannot establish causation or estimate melanoma risk attributable to melanotan II.
Publication & source
Why this paper is included
The compound is a named subject of the publication title.